Overcoming the Challenges to Treating Patients on Concomitant Opioid and Benzodiazepine Therapy

WebEx Evaluation | Post Assessment | CME Requirements

During this WebEx the presenter evaluated alternative therapies for the treatment of pain and anxiety, examined opioid and benzodiazepine tapering strategies, and discussed engaging patients in difficult conversations to promote safe and effective care.

Question Title

* 1. The speaker was knowledgeable, organized and effective.

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Rate your experience.	Rate your experience. Strongly agree	Rate your experience. Agree	Rate your experience. Neutral	Rate your experience. Disagree	Rate your experience. Strongly disagree

Question Title

* 2. The quality of the content provided in the presentation was credible and reflected best practices.

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Rate your experience.	Rate your experience. Strongly agree	Rate your experience. Agree	Rate your experience. Neutral	Rate your experience. Disagree	Rate your experience. Strongly disagree

Question Title

* 3. As a result of this learning session, I am now able to:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Discuss the increased morbidity and mortality associated with concomitant opioid and benzodiazepine therapy	Discuss the increased morbidity and mortality associated with concomitant opioid and benzodiazepine therapy Strongly agree	Discuss the increased morbidity and mortality associated with concomitant opioid and benzodiazepine therapy Agree	Discuss the increased morbidity and mortality associated with concomitant opioid and benzodiazepine therapy Neutral	Discuss the increased morbidity and mortality associated with concomitant opioid and benzodiazepine therapy Disagree	Discuss the increased morbidity and mortality associated with concomitant opioid and benzodiazepine therapy Strongly disagree
Summarize the evidence to support therapies for the treatment of anxiety, insomnia, and pain	Summarize the evidence to support therapies for the treatment of anxiety, insomnia, and pain Strongly agree	Summarize the evidence to support therapies for the treatment of anxiety, insomnia, and pain Agree	Summarize the evidence to support therapies for the treatment of anxiety, insomnia, and pain Neutral	Summarize the evidence to support therapies for the treatment of anxiety, insomnia, and pain Disagree	Summarize the evidence to support therapies for the treatment of anxiety, insomnia, and pain Strongly disagree
Evaluate strategies for tapering opioid analgesics and benzodiazepines	Evaluate strategies for tapering opioid analgesics and benzodiazepines Strongly agree	Evaluate strategies for tapering opioid analgesics and benzodiazepines Agree	Evaluate strategies for tapering opioid analgesics and benzodiazepines Neutral	Evaluate strategies for tapering opioid analgesics and benzodiazepines Disagree	Evaluate strategies for tapering opioid analgesics and benzodiazepines Strongly disagree
Develop strategies to engage patients in difficult conversations and outline appropriate patient selection for referral to specialty care	Develop strategies to engage patients in difficult conversations and outline appropriate patient selection for referral to specialty care Strongly agree	Develop strategies to engage patients in difficult conversations and outline appropriate patient selection for referral to specialty care Agree	Develop strategies to engage patients in difficult conversations and outline appropriate patient selection for referral to specialty care Neutral	Develop strategies to engage patients in difficult conversations and outline appropriate patient selection for referral to specialty care Disagree	Develop strategies to engage patients in difficult conversations and outline appropriate patient selection for referral to specialty care Strongly disagree

Question Title

* 4. I am knowledgeable of effective non-opioid therapies to treat chronic pain

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Rate yourself	Rate yourself Strongly agree	Rate yourself Agree	Rate yourself Neutral	Rate yourself Disagree	Rate yourself Strongly disagree

Question Title

* 5. I am knowledgeable of effective non-benzodiazepine therapies to treat anxiety disorders

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Rate yourself.	Rate yourself. Strongly agree	Rate yourself. Agree	Rate yourself. Neutral	Rate yourself. Disagree	Rate yourself. Strongly disagree

Question Title

* 6. I feel comfortable tapering my patients off opioid therapies

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Rate yourself.	Rate yourself. Strongly agree	Rate yourself. Agree	Rate yourself. Neutral	Rate yourself. Disagree	Rate yourself. Strongly disagree

Question Title

* 7. I feel comfortable tapering my patients off benzodiazepine therapies

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Rate yourself.	Rate yourself. Strongly agree	Rate yourself. Agree	Rate yourself. Neutral	Rate yourself. Disagree	Rate yourself. Strongly disagree

Question Title

* 8. Going forward, I will utilize assessment tools and Prescription Drug Monitoring Program (PDMP) data to evaluate the risk of medication misuse when prescribing opioids or benzodiazepines for long term use.

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Rate yourself.	Rate yourself. Strongly agree	Rate yourself. Agree	Rate yourself. Neutral	Rate yourself. Disagree	Rate yourself. Strongly disagree

Question Title

* 9. Please provide your credentials

Question Title

* 10. Contact information is required to receive CME certificate

Name

Company

Address

City/Town

State/Province

ZIP/Postal Code

Email Address

Phone Number

Question Title

* 11. Please provide any additional comments or recommendations.